Therese. Wiedmer, et.al., Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3)., Proceedings of the National Academy of Sciences of the United States of America, 2004, 101

http://rdf.ncbi.nlm.nih.gov/pubmed/15328404

Therese. Wiedmer, et.al., Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3)., Proceedings of the National Academy of Sciences of the United States of America, 2004, 101

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD08514
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD08514

allele

http://purl.org/net/cito/citesAsAuthority

• Plscr3<tm1Sims>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3053448

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating triglyceride level_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0001552I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• obese_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0001261I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• abnormal fat pad morphology_Plscr1<tm1Lex>/Plscr1<tm1Lex>
  http://metadb.riken.jp/0005334129SSvEvBrdPlscr1tm1LexPlscr1tm1LexPlscr1tm1LexPlscr1tm1Lex
• impaired glucose tolerance_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0005293I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• abnormal lipid homeostasis_Plscr1<tm1Lex>/Plscr1<tm1Lex>,Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0002118I129S7SvEvBrdC57BL6JPlscr1tm1LexPlscr1tm1LexPlscr3tm1SimsPlscr3tm1SimsPlscr1tm1LexPlscr3tm1Sims
• increased fat cell size_Plscr1<tm1Lex>/Plscr1<tm1Lex>
  http://metadb.riken.jp/0006094129SSvEvBrdPlscr1tm1LexPlscr1tm1LexPlscr1tm1LexPlscr1tm1Lex
• decreased adiponectin level_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0004893I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• abnormal circulating cholesterol level_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0000180I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• abnormal myelopoiesis_Plscr1<tm1Lex>/Plscr1<tm1Lex>,Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0001601I129S7SvEvBrdC57BL6JPlscr1tm1LexPlscr1tm1LexPlscr3tm1SimsPlscr3tm1SimsPlscr1tm1LexPlscr3tm1Sims
• increased fatty acid level_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0005281I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• abnormal lipid homeostasis_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0002118I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• impaired glucose tolerance_Plscr1<tm1Lex>/Plscr1<tm1Lex>,Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0005293I129S7SvEvBrdC57BL6JPlscr1tm1LexPlscr1tm1LexPlscr3tm1SimsPlscr3tm1SimsPlscr1tm1LexPlscr3tm1Sims
• abnormal abdominal fat pad morphology_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0000010I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• increased circulating leptin level_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0005669I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• increased white fat cell size_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0009118I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• hyperglycemia_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0001559I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• abnormal glucose homeostasis_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0002078I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims
• insulin resistance_Plscr3<tm1Sims>/Plscr3<tm1Sims>
  http://metadb.riken.jp/0005331I129SSvEvBrdC57BL6JPlscr3tm1SimsPlscr3tm1SimsPlscr3tm1Sims